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Abstract
A negative energy balance (NEB) is detrimental to reproduction in animals. A suggested link
between NEB and reproductive failure is the gastrointestinal hormone ghrelin, because of
the association between ghrelin and the hypothalamo-pituitary-gonadal axis. The [D-Lys3]-
Growth Hormone Releasing Peptide-6 ([D-Lys3]-GHRP-6) is a ghrelin antagonist that acts
on ghrelin receptors (GHS-R1). The objective of this study was to evaluate the effect of [D-
Lys3]-GHRP-6 on reproduction variables in feed restricted ewes. Two experiments were
conducted. Experiment I was conducted for 30 days; and Experiment II for 13 days. In both
experiments the ewes (n = 18) were randomly assigned to: Control (CO): fed to meet main-
tenance requirements; Feed restriction (FR): 80% of maintenance restriction; or Ghrelin
antagonist (GA): feed restricted and daily subcutaneous of 7.5μg/kg of [D-Lys3]-GHRP-6.
Plasma was collected to measure hormones and metabolite concentration. In Experiment II,
the hypothalamus and ovaries were collected on day 13. In both Experiments, sheep allo-
cated to the FR and GA treatments decreased their body weight compared with sheep in the
CO group (P < 0.06); progesterone however, did not differ between treatments (P > 0.10).
Experiment I: Plasma ghrelin concentration was greater (P < 0.01) in FR and GA compared
with CO ewes. Plasma non-esterified fatty acids concentration was greater (P < 0.01) in GA
and FR than CO. Experiment II: Kisspeptin1-Receptor (Kiss1-R) mRNA expression was
greater in FR (P < 0.01) and tended to be greater in GA (P = 0.10) compared with CO ewes.
The neuro peptide-Y (NPY) mRNA expression was greater (P = 0.03) in FR than CO; and
tended to be greater (P = 0.06) compared with GA ewes. Growth hormone releasing hor-
mone (GhRH) mRNA expression was greater in GA (P = 0.04) and tended to be greater in
FR (P = 0.07) compared with CO ewes. Feed restriction increased GhRH, NPY, and Kiss-R
mRNA expression in hypothalamus without affecting reproductive variables.Ghrelin antago-
nist may prevent an increase inNPY expression in ewes.
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Introduction
Ruminants affected by a negative energy balance (NEB) are subjected to metabolic change [1].
The metabolic change includes the regulation of complex signaling pathways that result in
nutrient partitioning, and ultimately can impair the estrus cycle in cattle [1]. Plasma ghrelin
concentration increases in sheep [2] and humans [3] during the pre-prandial period. In addi-
tion, plasma ghrelin concentration increases during feed restriction compared with rams given
ad-libitum intake [4].Ghrelin, is an endogenous ligand for the growth hormone secretagogue
receptor (GHS-R1a) [5]. In the brain, the binding of ghrelin to GHS-R1a stimulates growth
hormone (GH) secretion [5], up-regulates growth hormone release hormone (GHRH) [6],
and increases food intake regulating energy balance [7]. Ghrelin also plays a role in the
hypothalamo-piuitary-gonadal axis. Ghrelin inhibits the secretion of gonadotropin release
hormone (GnRH) in the hypothalamus of rats [8]. Additionally, ghrelin decreases plasma
luteal hormone (LH) concentration in sheep [9]. The release of GnRH by the hypothalamus
stimulates LH synthesis and secretion from the hypophysis. When both hormones, GnRH and
LH, are affected there is a dysfunction on the reproductive cycle [10]. As a consequence, fertil-
ity and reproductive behavior of the animals are compromised. Another possible mechanism
of how ghrelin regulates reproduction is by suppressing kisspeptin (Kiss1) secretion. Kisspep-
tin is a hypothalamic neuropeptide that stimulates GnRH release [11].
Ghrelin has been associated with an increase in mRNA concentration of orexigenic neuro-
peptides like neuropeptide Y (NPY) and agouti-related protein (AgRP) [4]; both neuropep-
tides increased feed intake and energy expenditure [12]. The NPY and AgRP neuropeptides
not only regulate feed intake, but also, regulate the reproductive hypothalamus-piuitary-
gonadal axis [13]. For example, the infusion of an NPY agonist decreased the release of gonad-
otropin in sheep [14].
The GHS-R1a receptor was immuno-localized in granulosa cells from follicles at all devel-
opmental stages and in luteal cells of corpus luteum (CL) in ewe ovaries [15]. The greatest
expression of GHS-R1a in ovaries is during the CL development and lesser expression is dur-
ing CL regressing phase [15]. In pigs, an increased in plasmaghrelin concentration has a nega-
tive effect on plasma progesterone concentration [16]. The effect of ghrelin on progesterone
synthesized by the CL has not been reported in ewes. The direct effect of ghrelin in the CL
could be one of the mechanisms by which NEB affects reproduction.
The [D-Lys3]-Growth Hormone Releasing Peptide-6 ([D-Lys(3)] -GHRP-6) is a ghrelin
antagonist. In-vivo and in-vitro experiments determine that [D-Lys3]-GHRP-6 binds to
GHS-R1a [17, 18]. Some of the traits negatively affected by ghrelin were antagonized by
[D-Lys 3]—GHRP-6, such as decreasing male sexual behavior, LH gene expression [19], and
feed intake in rats [20].
We hypothesized that food restriction increases plasma ghrelin concentration. Further-
more, we hypothesized that ghrelin, by activating its receptor, compromises the reproductive
cyclicity. This is due to changes on the mRNA of energy balance neuropeptides, reproductive
neuropeptides, hormones, and their receptors in the hypothalamus; and modifying the mRNA
of stereological enzymes in ovaries. As a consequence, ewes in NEB will have a low plasma pro-
gesterone concentration. However, those effects are suppressed by blocking ghrelin activity
with [D-Lys3]-GHRP-6. The objective of the present study was to evaluate the effect [D-Lys3]-
GHRP-6 in reproduction variables in feed restricted ewes.
Materials and method
All animal procedures were approved by the Agricultural Animal Care and Use Committee of
The Ohio State University (IACUC # 2016A00000089). The Experiments were conducted in
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the sheep research center of the Ohio Agricultural Research and Development Center. To test
our hypothesis, we carried out two experiments.
Animals, treatments, and sampling for Experiment I
This Experiment was performed to evaluate one complete estrus cycle. During this period
plasma progesterone concentration and ovarian activity were evaluated.
During the breeding season eighteen ewes (80.1 ± 1.56 kg and 2.5–3 in a five scale of body
condition score; [21]) were allotted in pairs to pens and synchronized with prostaglandin
(estrumate, PG600, Merck, Washington, IA, USA) at days 1 and 9 (1.7μg/kg, IM) as described
by Gottfredson [22]. Day 1 was considered the first day of the experiment. Each pen was ran-
domly assigned to one of the following three treatments: (i) Control (CO): ewes fed a diet that
provided the maintenance nutrient requirements for a ewe and given a daily subcutaneous
(SC) saline infusion (0.1mL/kg body weight,BW); (ii) Feed restriction (FR): ewes were fed a
diet restricted to 80% of maintenance requirements and given a daily subcutaneous (SC) saline
infusion (0.1mL/kg BW); (iii) Ghrelin antagonist (GA): the same restricted diet as the FR and
given a daily subcutaneous (SC) ghrelin antagonist infusion (7.5μg/Kg BW of [D-Lys3]-
GHRP-6 diluted into 0.1ml/kg BW of saline solution; Phoenix Pharmaceuticals, INC. Burlin-
game, CA, USA). Antagonist dose used was based previous studies [23, 24].
The experiment was conducted over 30 days. During this period ewes were infused daily
before feeding (between 0800 to 0900). For the CO group the feed offered was a mixed diet
containing 2kg of corn silage, 0.225 kg of soy hull and 0.09 kg of distillers grains with solubles,
totaling of 2.3 kg animal feed/day. Ewes in the FR and GA groups were given 80% of the main-
tenance diet (1.76 kg/animal/day, 20% restriction). There was no feed refusal during the length
of the study. The chemical composition and nutrient analysis of the diet is described in
Table 1.
Ewes were weighed and blood sampled before the infusions on days 1, 9, 12, 16, 19, 23, 26,
and 30 to measure plasma glucose, NEFA, and progesterone concentrations; plasma ghrelin
concentration were analyzed from the day 30 samples. Transrectal ultrasounds (E. I. Medical





Mineral and vitamin supplement 1.72





NE m 4/, Mcal/kg 1.6
1Contained 36.14% DM, 4.87% CP, 1.6% EE, 38.86% NDF and 3.67% ASH (DM basis).
2 Contained 86.73% DM, 1.73% CP, 0.07% EE, 0.38% NDF and 0.241% ASH (DM basis).
3Contained 88.4% DM, 1.33% CP, 0.33% EE, 1.85% NDF and 0.41% ASH (DM basis).
Abbreviation: NDFa, apparent neutral detergent fiber; EE, ether extract; CP, crude protein; ASH, ashed sample
weight.
4Estimated valued using NEm values from the Nutrient Requirement of Small Ruminants (NRC 2007).
https://doi.org/10.1371/journal.pone.0238465.t001
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imaging Ibex Pro–unit E. I. Medical L62L transducer) were carried out to evaluate ovarian
activity on days 9, 16 and 26. During blood sampling, 10mL was collected from a jugular vein
and transferred to tubes with disodium EDTA and benzamidine hydrochloride (1.6 and 4.7
mg/mL of blood, respectively) and placed on ice. After centrifugation for 25 min (1,800 ×gat
4˚C), plasma was aliquoted and stored at -80˚C until analysis.
Animals, treatments, and sampling for Experiment II
The Experiment II was carried out to analyze hypothalamus mRNA concentration for neuro-
peptides and metabolic hormone receptors, ovarian mRNA stereological enzymes, hormones,
and receptors, and to evaluate ovarian macroscopic structures, such as corpus luteum (CL)
and preovulatory follicles.
The procedure of this Experiment was explained in Carranza Martin et al. [24]. Briefly,
eighteen ewes (85.5 ± 1.06 kg and 2.5–3 in a five scale of body condition score; 21) had their
estrus cycle synchronized and were assigned to the same treatments as mentioned in Experi-
ment I. Ewes were infused every day before feeding for 13 days. Sheep in CO group were fed
1.5 times greater than the dietary maintenance requirements for a ewe based on the NRC
requirement [25]. Ewes were given a total of 3.5 kg of dry matter (DM) intake/day, with 3.04
kg of corn silage, 0.32 kg of soy hull and 0.14 kg of soybean meal on DM basis. Ewes allocated
to the FR and GA groups were given the same diet but at a rate of 80% of the NRC mainte-
nance requirement [25] with a total feed intake of 1.87 kg/animal/day. As in Experiment I
there were no feed refusals during the experiment. The same diet as described in Table 1 was
given to the ewes in Experiment II.
Ewes were weighed and blood sampled before the infusion on days 1, 4, 9 and 13 to measure
plasma glucose, NEFA, and progesterone concentrations. Blood samples were collected, ali-
quoted and stored as reported in Experiment I. On day 13 all ewes were euthanized, and the
hypothalamus and ovaries were removed. The hypothalamus collection technique was as
described by Glass et al. [26]. Ovaries were macroscopically evaluated within 5 minutes of har-
vest and then frozen. The left ovary and the hypothalamus of each ewe was then flash frozen in
liquid N2 and stored at -80˚C until analysis.
Laboratory analysis for Experiments I and II
Plasma glucose and NEFA concentrations were measured using a colorimetric assay (1070
Glucose Trinder, Stanbio Laboratory,1261 North Main Street Boerne, Texas 78006; 96-well
serum/plasma fatty acid kit non-esterified fatty acids detection 500 point kit, Zenbio Labora-
tory, NC; respectively) according to the manufacturer protocol. Plasma progesterone concen-
tration was measured using commercial ELISA kit (BioMetallics In., Princeton Junction,
NJ08550). The sensitivity of the assay was 0.4 ng/mL and the intra and inter assay coefficient
of variation were 1.9% and 1%, respectively. The area under the curve (AUC) was calculated in
Experiment I to measure the total of progesterone in one cycle (from d 9 to 30).
Plasma ghrelin was measured by RIA using an octanolyated ghrelin kit (Active Ghrelin Kit
GHRA-88HK, Linco Research, St. Charles, MO), as described and validated for sheep previ-
ously [4]. The intra assay coefficient of variation was 7.8%.
Hypothalamus and ovaries were used to evaluate mRNA relative abundance. The genes
evaluated were chosen due to their role in metabolism and reproduction functions. Genes ana-
lyzed from hypothalamus (Table 2) were neuropeptide Y (NPY), NPY receptor 1 (NPY1R),
NPY receptor 2 (NPY2R), agouti related protein (AgRP), pro-opiomelanocortin (POMC),
cocaine and amphetamine regulated transcript (CART),melanocortin receptor 3 (MCR3),mela-
nocortin receptor 4 (MCR4), kisspeptin (Kiss1), Kiss1 receptor (Kiss1R), gonadotrophin release
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hormone (GnRH), estrogen receptor 1 (ER1), estrogen receptor 2 (ER2), growth hormone release
hormone (GhRH), and growth hormone receptor (GH-R). Genes analyzed from ovaries were
(Table 2): aromatase (CYP19), steroid acute regulatory protein (STAR), ghrelin receptor
(GHSR), and preproghrelin (GHRL). The RNA was extracted by Trizol1 following the
instructions of the manufacturer, and a sample of 175 ng of RNA was used to measure mRNA
relative abundance using NanoString technology [27]. The mRNA relative abundance for each
gene was normalized using 4 housekeeping genes (GAPDH, ciclophilin A, PGK1, beta 2 micro-
globulin, and beta- actin) using nSolver software.
The weight (g) of the right and left ovary from each ewe was recorded and a caliper was
used to measure the height, width and length (cm).The number of CL and preovulatory folli-
cles (>6mm) were counted. The volume (cm3) of both ovaries per ewe was calculated as
described by Chen et al. [28].
Table 2. Hypothalamic and ovarian genes for the NanoString procedure.




























1Kiss1, kisspeptin; Kiss1R, Kiss1 receptor; GnRH, gonadotrophin release hormone; ER1, estrogen receptor 1; ER2,
estrogen receptor 2; GhRH, growth hormone release hormone; NPY, neuropeptide Y; NPY1R, NPY receptor 1;
NPY2R, NPY receptor 2; AgRP, agouti related protein; POMC, pro-opiomelanocortin; CART, cocaine and
amphetamine regulated transcript; MCR3, melanocortin receptor 3; MCR4, melanocortin receptor 4; GhRH, growth
hormone release hormone; GH-R, growth hormone receptor; CYP19, aromatase; STAR, steroidogenic acute
regulatory protein; GHSR, Ghrelin receptor; GHRL, preproghrelin; GADPH, glyceraldehyde 3-phospate
dehydrogenase; PGK1, Phosphoglycerate kinase 1.
https://doi.org/10.1371/journal.pone.0238465.t002
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Statistical analysis for Experiments I and II
Data was analyzed with a mixed procedure of SAS (9.4) as a randomized design. Plasma glu-
cose, NEFA, plasma progesterone concentrations, and BW were analyzed as repeated measure-
sin time using the MIXED procedure of SAS (9.4, SAS Institute, Cary, NC). The model
included the fix effect of treatment, time, their interaction, and the random effect of pen.
Plasma ghrelin concentration and mRNA relative abundance were analyzed by PROX MIXED
model (SAS Institute, Cary, NC), using a similar model but without time and its interaction.
For mean separation on the time by treatment interaction the SLICE option of SAS was used.
If there was no time by treatment interaction, a non-orthogonal contrast was used as a mean
separator, comparing the three treatments among each other. Significance for main effects was
set at P� 0.05 and tendencies were determined at P� 0.10 and P> 0.05.
Results
Experiment I
Ewes allocated to the FR and GA treatments had similar plasma ghrelin concentrations
(P = 0.60; Table 3). The FR and GA treatments however, showed greater plasma ghrelin con-
centrations than the CO group (P<0.01). There tended to be a treatment by time interaction
in BW between CO and, FR and GA (P = 0.06). Ewes in the FR and GA treatment groups
showed a trend to decrease BW during the experiment in comparison with the CO ewes (BW
(kg): CO initial 79.13 ± 3.01 to final 78.3 ± 2.63; GA initial 80.37 ± 3.01 to final 75.53 ± 2.7; FR
initial 80.8 ± 2.69 to final 74.67 ±1.87; Fig 1). There were no differences in plasma glucose con-
centration among groups (P�0.25; Table 3). There was a treatment by time interaction for
plasma NEFA concentration (P = 0.01). Feed restricted groups increased their plasma NEFA
concentrations over the course of the experiment whereas CO NEFA plasma concentration
did not change (NEFA (μM): CO initial 10.44 ± 1.74 to final 14.72 ± 3.21; GA initial
10.04 ± 1.39 to final 35.85 ± 3.7; FR initial 10.75 ± 2.34 to final 21.08 ± 2.34; Fig 2).
All ewes presented an active estrus cycle. The active estrus cycle was characterized by follicle
growth, CL structure, and an increase in plasma progesterone concentration on 17 ± 0.6 days.
Plasma progesterone concentration of the CO treated ewes was lesser than the GA treated
ewes (P < 0.05), but plasma progesterone for the CO and GA treatments were not different to
the FR treated ewes (P� 0.20). There was no difference among treatments for plasma proges-
terone concentration as quantified by the AUC (P� 0.17; Table 3).
Experiment II
There was a treatment by time interaction in BW (P< 0.01). Ewes allocated to the FR and GA
groups decreased their body weight over the course of the experiment compared with the body
Table 3. Experiment I: Plasma ghrelin, glucose, and progesterone concentrations in ewes with a maintenance diet (CO), restricted diet (FR) and restricted diet with
ghrelin antagonist infusion (GA) for 30 days.
Treatments SEM P- Values
CO GA FR CO vs GA CO vs FR GA vs FR Treat by Time
Ghrelin (pmpl/mL) 16.11 29.13 31.46 3.51 <0.01 <0.01 0.60
Glucose (mg/dl) 55.43 54.48 54.54 1.62 0.70 0.72 0.98 0.25
Progesterone (ng/ml) 4.96 5.77 5.37 0.26 0.03 0.27 0.29 0.20
Prog AUC1 85.57 102.4 95.66 7.58 0.17 0.40 0.54
1 AUC: Area Under the Curve. Means were calculated based on the overall values of each treatment.
https://doi.org/10.1371/journal.pone.0238465.t003
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weight of ewes allocated to the CO group that did not change throughout the experiment (BW
(kg): CO initial 85.28 ± 3.55 to final 86.1 ± 3.36; GA initial 83.77 ± 3.55 to final 79.17 ± 3.23;
FR initial 85.43 ± 3.64 to final 79.13 ± 3.08; Fig 3).
Plasma progesterone concentration was not different among the treatments (P� 0.21).
Ovaries from ewes allocated to the GA treatment had less volume (P = 0.02) and tend to
weighed less (P = 0.07) than ovaries from the CO treated ewes. There were no differences in
the volume and weight of ovaries from the GA and FR treated ewes (P� 0.34). Likewise, there
was no difference in ovary volume or weight between CO and FR treatments (P� 0.14;
Table 4). There was no difference in the number of CL and preovulatory follicles among the
treatment groups (P� 0.40).
The relative expression of mRNA for Kiss1 in the hypothalamus was not different among
groups (P� 0.94). The ewes in the FR treatment however, had greater mRNA relative expres-
sion of Kiss1R than CO (P< 0.01). The Kiss1R mRNA relative expression in GA ewes tended
to be greater than CO (P = 0.10) and was not different from the FR treated ewes (P = 0.22)
(Table 5). The relative expression of mRNA for GnRH, ER1 and ER2 was not different among
groups (P� 0.13) (Table 5). The NPY mRNA relative expression (Table 5) was greater
(P = 0.03) in the FR treated ewes compared with the CO treated ewes. The FR treated ewes
tended to have greater mRNA relative expression for NPY (P = 0.06) when compared with the
GA treated ewes; however, there were no differences in NPY1R and NPY2R mRNA relative
expression (P�0.36) among groups (Table 5). The mRNA relative expression for AgRP was
Fig 1. Body weight (kg) during 30 days of treatment of synchronized ewes. Treatments were: (i) Control (CO): ewes fed a
diet that provided the maintenance nutrient requirements for a ewe and given a daily subcutaneous (SC) saline infusion
(0.1mL/kg body weight, BW); (ii) Feed restriction (FR): ewes were fed a diet restricted to 80% of maintenance and given a
daily SC saline infusion (0.1mL/kg BW); (iii) Ghrelin antagonist (GA): the same restricted diet as the FR and given a daily
SC ghrelin antagonist infusion (7.5μg/Kg BW of [D-Lys3]-GHRP-6 diluted into 0.1ml/kg BW of saline solution). The FR
and GA treatment decrease the BW in comparison with CO showing a time by treatment interaction (P = 0.06).
https://doi.org/10.1371/journal.pone.0238465.g001
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not different among groups (P>0.10; Table 5). Neither were there differences (P� 0.12)
between groups for the anorexigenic neuropeptides, POMC and CART, nor the receptors
MCR3 and MCR4 mRNA relative expression (Table 5). The GhRH mRNA relative expression
was greater in GA treated ewes compared with the ewes in the CO group (P = 0.04). There was
a trend for a greater relative expression of GhRH mRNA from the FR treated ewes compared
with the ewes from the CO treatment (P = 0.07; Table 5). There were no differences in GH-R
mRNA relative expression between groups (P� 0.15) (Table 5). There were no differences in
ovarian mRNA relative expression of CYP19, STAR, GHS-R, and GHRL among treatments
(P� 0.11) (Table 5).
Discussion
Negative energy balance impacts reproduction by affecting the estrus cycle, pregnancy success
and/or the number of offspring in sheep [29]. A suggested link between this nutritional status
and reproduction is the hormone ghrelin, due to its association with the hypothalamus-pitui-
tary-gonadal axis [30].
In the current experiment a small feed restriction did not change plasma progesterone con-
centration and follicular activity, despite the changes in plasma NEFA and ghrelin
Fig 2. Plasma NEFA (μM) concentration during 30 days of treatment of synchronized ewes. Treatments were: (i)
Control (CO): ewes fed a diet that provided the maintenance nutrient requirements for a ewe and given a daily
subcutaneous (SC) saline infusion (0.1mL/kg body weight, BW); (ii) Feed restriction (FR): ewes were fed a diet restricted to
80% of maintenance and given a daily SC saline infusion (0.1mL/kg BW); (iii) Ghrelin antagonist (GA): the same restricted
diet as the FR and given a daily SC ghrelin antagonist infusion (7.5μg/Kg BW of [D-Lys3]-GHRP-6 diluted into 0.1ml/kg
BW of saline solution). The FR and GA ewes increased their NEFA plasma concentration during the experiment in
comparison with CO showing a time by treatment interaction (P = 0.01). � indicate treatments differences (P� 0.04)
evaluated using the SLICE option in SAS.
https://doi.org/10.1371/journal.pone.0238465.g002
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concentrations. One explanation is that the restriction of 20% was not low enough to provoke
an impact on reproduction. Another explanation could be that ewes, previous to this study,
were well fed to maintain a good BCS. For that reason, ewes had energy reserves, such as adi-
pose tissue, that allowed them to continue with the reproductive cycle despite having a feed
restriction. The endocrine responses to under nutrition in ewes are dependent on the initial
body energy reserves of the animal [31].
Fig 3. Body weight (BW, kg) during 13 days of treatment of synchronized ewes. Treatments were: (i) Control (CO): fed
1.5 times greater than the dietary maintenance and given a daily subcutaneous (SC) saline infusion (0.1mL/kg BW) (ii) Feed
restriction (FR): ewes were fed a diet restricted to 80% of maintenance and given a daily SC saline infusion (0.1mL/kg BW);
(iii) Ghrelin antagonist (GA): the same restricted diet as the FR and given a daily SC ghrelin antagonist infusion (7.5μg/Kg
BW of [D-Lys3]-GHRP-6 diluted into 0.1ml/kg BW of saline solution). Time by treatment interaction P-value< 0.01. �
indicate treatments differences (P� 0.05) evaluated using the SLICE option in SAS.
https://doi.org/10.1371/journal.pone.0238465.g003
Table 4. Experiment IImean (± SEM) body weight, plasma progesterone concentration, ovarian volume, weight, number of corpus luteum and number of follicles
in ewes treated with a maintenance diet (CO), restricted diet (FR) and restricted diet with ghrelin antagonist infusion (GA) for 13 days.
Treatments SEM P-Values
CO GA FR CO vs GA CO vs FR FR vs GA Treat by Time
Progesterone (ng/ml) 3.58 4.40 4.61 0.5 0.21 0.70 0.40 0.50
Ovaries variables1
Ov. Vol (cm3) 2.3 1.67 1.92 0.18 0.02 0.15 0.34
Ov. W (g) 2.55 1.9 2.04 0.21 0.07 0.14 0.65
CL 1.5 1.58 1.25 0.28 0.83 0.53 0.40
Follicle 0.67 1.17 1.08 0.23 0.14 0.21 0.80
1 Ov. Vol: Ovaries volume; Ov. W: Ovaries weight; CL: Corpus luteum per ovary; Follicle: Follicles bigger than 6mm per ovary. Means were calculated based on the
overall values of each treatment.
https://doi.org/10.1371/journal.pone.0238465.t004
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Plasma ghrelin concentration has been reported to increase during fasting and the pre-
prandial period [2]. Plasma ghrelin concentration was greater for ewes on the feed restricted
diets (FR and GA groups; Experiment I). In addition, as discussed in Carranza Martin et al.
[24], ghrelin concentration in a short period of time showed a tendency to be greater in GA
ewes in comparison with CO ewes (26.43 pM/mL vs. 14.68 pM/mL, respectively)but there
were no differences in ghrelin concentrations between theCO and FR (26.16 pM/mL).
The GA and FR ewes decreased BW in comparison with CO ewes during both Experi-
ments, I and II. Also, ewes from FR and GA treatments in Experiment I increased their plasma
NEFA concentration. In ruminants, NEB is associated with a loss in BW and increased plasma
NEFAconcentration. These results showed that in both experiments ewes from FR and GA
were in a NEB.
In our hypothesis we expected that FR ewes would suffer an estrus cycle disruption due to
ghrelin’s action on the ovary, which would be reflected in a low plasma progesterone concen-
tration. Furthermore, it was expected that the infusion of a ghrelin antagonist would overcome
the estrus cycle disruption. Our study demonstrated no difference between FR and CO ewes
for plasma progesterone concentration in both experiments. This contrasts with a study in rats
that used the intra-ventricular infusion of 3 nM of ghrelin to cause a decrease in serum proges-
terone concentration [32]. The supraphysiological doses of ghrelin used in this study, however,
Table 5. Hypothalamic and ovary mRNA relative expression of receptors, growth hormone release hormone and steroidogenic enzymes in ewes with a maintenance
diet (CO), restricted diet (FR) and restricted diet with ghrelin antagonist infusion (GA) for 13 days.
Treatments SEM P values
CO GA FR CO vs GA CO vs FR FR vs GA
Hypothalamus genes
KISS1 302.38 301.55 304.19 24.29 0.98 0.96 0.94
KISS1-R 10.99 13.96 16.12 1.20 0.10 <0.01 0.22
GnRH 33.41 41.38 56.98 10.45 0.60 0.13 0.31
ER1 273.30 266.35 287.31 11.38 0.68 0.42 0.24
ER2 49.42 42.06 50.54 4.35 0.25 0.86 0.19
NPY 358.64 378.89 529.37 51.29 0.78 0.03 0.06
NPY1R 213.93 212.63 215.10 10.05 0.93 0.93 0.86
NPY2R 79.35 78.41 84.78 4.54 0.89 0.43 0.36
AgRP 28.99 37.87 74.38 17.77 0.74 0.12 0.20
POMC 460.48 509.54 509.29 52.33 0.53 0.53 0.99
CART 800.58 648.90 773.42 81.73 0.21 0.82 0.30
MCR3 31.07 25.14 33.85 3.19 0.23 0.56 0.10
MCR4 11.05 10.52 11.18 1.72 0.83 0.96 0.79
GhRH 76.99 119.51 114.16 13.45 0.04 0.07 0.80
GH-R 118.34 128.84 132.81 6.74 0.29 0.15 0.68
Ovary genes
CYP19 5.72 28.92 3.61 9.58 0.13 0.88 0.11
Star 137.7 106.3 61.8 64.04 0.64 0.43 0.74
GHS-R 1.74 3.85 3.68 0.97 0.17 0.20 0.90
GHRL 1.4 2.88 2.11 0.8 0.26 0.57 0.66
1Kiss1, kisspeptin; Kiss1R, Kiss1 receptor; GnRH, gonadotrophin release hormone; ER1, estrogen receptor 1; ER2, estrogen receptor 2; NPY, neuropeptide Y; NPY1R,
NPY receptor 1; NPY2R, NPY receptor 2; AgRP, agouti related protein; POMC, pro-opiomelanocortin; CART, cocaine and amphetamine regulated transcript; MCR3,
melanocortin receptor 3; MCR4, melanocortin receptor 4; GhRH, growth hormone release hormone; GH-R, growth hormone receptor; CYP19, aromatase; STAR,
steroidogenic acute regulatory protein; GHS-R, ghrelin receptor; GHRL, preproghrelin.
https://doi.org/10.1371/journal.pone.0238465.t005
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may have contributed to the decrease in plasma progesterone concentration in the rats [32].
Moreover, others have reported that ghrelin concentration increased and LH concentration
decreased when feed restricting cows and heifers but blood progesterone concentration did
not change [33]. The restricted period implemented by Chouzouris et al. [33] was shorter than
the period used in Experiment I; but it had a similar time period as Experiment II. It is possible
that in the bovine and ovine, blood progesterone concentration is not associated with plasma
ghrelin concentration. However, in the current study, administration of ghrelin antagonist for
a period of 30 days increased plasma progesterone concentrations. We cannot explain how-
ever, the physiological mechanism behind the increase in plasma progesterone concentration
when a ghrelin antagonist is given to a ewe.
Based on our hypothesis we were expecting to find a lesser volume in the ovaries of the FR
ewes compared with the ovaries in the CO ewes because of the lack of large structures such as
corpus luteum and follicles within the ovary. In addition, we expected a lesser mRNA abun-
dance of the steroidogenic enzymes in the ovaries of the FR ewes than the CO ovaries. These
effects would be counteracted with the use of the ghrelin antagonist. From our results, block-
ing the receptor with a ghrelin antagonist did not change the relative mRNA expression within
the ewes’ ovarian tissue. The weights and volume of the CO ovaries however, were greater
when compared with the ovaries of the GA treated ewes. The number of CL and follicles were
not different for either of the two treatments; which leads us to assume that the increase in the
weight and volume could be due to a greater amount of connective tissue or smaller structures,
such as primary and secondary follicles. The presence of GHS-R has been reported in the
stroma, the ovarian surface epithelium, primary and secondary follicles, granulosa cells, and
CL in ewes [34]. Chronic ghrelin infusion decreased the diameter of follicles and CL in rats
and decreased the diameter of other ovarian structures and, as a consequence, the whole ovar-
ian volume was smaller in the treated animals compared with the control group [35]. Despite
the difference observed in the ghrelin antagonist and control group, ewes in feed restriction
alone did not present differences compared with the other treatments.
The addition of ghrelin (10 and 100 ng/mL) in bubaline CL culture produce a decrease in
cytochrome P45011A1and 3-beta-hydroxysteroid dehydrogenase mRNA expression, but did
not show a decrease in STAR mRNA expression [36]. The addition of ghrelin to in-vitro oocyte
during maturation demonstrated a decrease in aromatase enzyme protein in pigs [37]. The
lack of modification in the relative expression of mRNA of CYP19, STAR, GHS-R, and GHRL,
in the present study could be explained by the short-term restriction (13d) or that the change
in plasma ghrelin concentration was not enough to show differences in Experiment II.
The binding of Kiss1 to its hypothalamic receptor (Kiss1-R) produces the secretion of the
GnRH that regulates the secretion of LH and follicle-stimulating hormone (FSH) in rats [38].
Ghrelin administration (intravenous, 3nM/250μL) down regulates Kiss1mRNA expression
without changing the Kiss1-R mRNA abundance [39]. The mRNA expression of hypothalamic
Kiss1 and Kiss1-R decrease after short-term fasting with an attenuation of the hypothalamus-
pituitary-gonadalaxis in monkeys (Macaca mulatta) [40]. In contrast, we found a greater
Kiss1-R mRNA abundance in FR and GA ewes compared with the Kiss1-R mRNA abundance
of CO ewes. There was no change in the abundance of Kiss1 and GnRH mRNA expression
between groups. We therefore suggest that changes in the expression of mRNA for Kiss1-R are
not associated with the mRNA expression of GnRH. The Kiss1 neurons express both estradiol
receptors (ER; 1 and 2). Estradiol ER1 has been implicated in the positive feedback LH surge
and ovulation [41] in mice. Additionally, GHS-R and ER1 are co-expressed in many hypotha-
lamic areas in mice [42]. However, in the present study ER1 and ER2 mRNA expression were
not different between treatments.
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Another possibility for the effect of ghrelin on theactivity of the hypothalamus-pituitary-
gonadal axis is through orexigenic neuropeptides. We hypothesized that FR treated ewes
would present an increasein orexigenic neuropeptides and decrease anorexigenic peptides.
These changes would affect the relative expression of mRNA of Kiss1 and/or GnRH, inducing
anestrus in the ewe. Changes in plasma concentration of ghrelin because of feed restriction
had been associated with changes in mRNA expression of the neuropeptides NPY, AgRP and
POMC [4, 43]. In Experiment II we observed an increased in mRNA abundance for NPY asso-
ciated with feed restriction. The mRNA abundance for NPYwas less when feed restricted ewes
were infused with a ghrelin antagonist. Chronic administration of NPY causes reproductive
failure [44]. The effect of NPY on GnRH varies depending on the physiological stage of the
animal. In fed mice, acute infusion of NPY increases GnRH secretion. However, chronic
administration of NPY causes reproductive failure [44] by inhibiting GnRH neurons and dis-
rupting the hypothalamus-pituitary-gonadalaxis [8]. Besides the significant increase in the
abundance of NPY mRNA in FR ewes, there was no change in GnRH mRNA expression. We
did not found differences in the expression of the ER1, ER2, NPY1R, NPY2R, ARP, POMC,
CART, MCR3, and MCR4 mRNA, we suggest that it is possible that the ewes energy reserves,
and or the 13 days of food restriction was insufficient time to observe these changes.
We expected that the relative expression of mRNA GhRH in FR would be greater than the
GA and CO groups. Ghrelin stimulates growth hormone (GH) secretion [5] and also has a
synergistic effect with GhRH on the hypothalamus [45]. In our results we found that GhRH
mRNA relative expression was greater in FR and GA groups, even when the ghrelin receptor
was blocked by [D-Lys-3]-GHRP-6. The infusion of NEFA into rats increases plasma GH con-
centration [46]. It is possible that the secretion of GH could be regulated via changes on GhRH
caused by the infusion of NEFA. Therefore,the increase in plasma NEFA concentration in the
current experiment may explain the lack of change in relative mRNA expression of GhRHin
the [D-Lys-3]-GHRP-6 infused ewes.
Conclusion
We can conclude that a small feed restriction does not modify plasma progesterone concentra-
tion and ovarian cyclicity in ewes with a good body condition score. Short term ghrelin antag-
onist infusion in feed restricted ewes does not affect ovarian follicles and CL number, the
mRNA expression of STAR and aromatase. However, ghrelin antagonist modifies ovarian vol-
ume and weight. A short term infusion of ghrelin antagonist changes the abundance of NPY
and Kiss1-R mRNA in the hypothalamus of feed restricted ewes but not in Kiss1, GnRH, ER1,
ER2, NPY1R, NPY2R, AgRP, POMC, CART, MCR3, and MCR4 mRNA abundance. The
abundance of GhRH mRNA was increased in feed restricted ewes in both groups, FR and GA;
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